Otros idiomas Vincerx Pharma, Inc.

Acciones

VINC

US92731L1061

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,81 ^USD	+9,46 %		+35,00 %	-31,36 %

14/05	Vincerx Pharma, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
26/04	El repunte tecnológico impulsa a los fondos cotizados y a los futuros de renta variable antes de las campanadas del viernes	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	14/05
Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	26/04
Vincerx Pharma Prices Public Offering of Shares, Warrants	26/04
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants	26/04
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants	25/04
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09/04
Top Premarket Decliners	09/04
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell	09/04
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024	08/04
Vincerx Pharma, Inc. Presents Positive Preliminary Phase 1 Data for Vip236 and Updates on Pipeline Progress At the American Association for Cancer Research Annual Meeting 2024	08/04
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	01/04
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	29/03
Vincerx Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	05/03
Vincerx Pharma Shares Jump After Results of Blood Cancer Treatment Trial	08/01
Top Premarket Gainers	08/01
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07/01
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Vincerx Pharma, Inc.

Acciones

VINC

US92731L1061

Otros idiomas

Filtros